4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-010808
CHIEF OPERATING OFFICER sold 12,000 shares at an average $20.48 ($245,812)
- CHIEF OPERATING OFFICER acquired 7,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessari Eben CHIEF OPERATING OFFICER | 2025-04-14 | Option exercise 10b5-1 | +7,000 | $3.80 | $26,600 | 89,363 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-04-14 | Sale 10b5-1 | −5,579 | $20.19 | $112,640 | 83,784 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-04-14 | Sale 10b5-1 | −6,421 | $20.74 | $133,172 | 77,363 | D |
| Derivatives | |||||||
| Tessari Eben CHIEF OPERATING OFFICER | 2025-04-14 | Option exercise · Share Option 10b5-1 | −7,000 | 7,049 | D | ||
| Open-market sales · 12,000 sh · avg $20.48 · $245,812 | |||||||
Loading xslF345X05/form4-04162025_080444.xml…